Stay updated with breaking news from Nasdaq Atra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.62 and traded as low as $0.55. Atara Biotherapeutics shares last traded at $0.57, with a volume of 1,833,007 shares trading hands. Analyst Upgrades […]
Equities research analysts at StockNews.com began coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Several other research firms have also commented on ATRA. HC Wainwright lowered shares of Atara Biotherapeutics from a […]
StockNews.com initiated coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. ATRA has been the subject of a number of other reports. Mizuho cut shares of Atara Biotherapeutics from a buy rating to a neutral […]
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have been assigned a consensus rating of “Hold” from the four brokerages that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 12,270,000 shares, an increase of 6.3% from the September 30th total of 11,540,000 shares. Based on an average daily trading volume, of 1,170,000 shares, the days-to-cover […]